A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC

Clinical trial NCT03392064 · SUSPENDED

Trial details

NCT number: NCT03392064
Sponsor: Amgen
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2018-09-10
Primary completion: 2028-01-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.